Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 52 (1) , 66-68
- https://doi.org/10.1016/s0015-0282(16)60790-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Progesterone-associated proteins PP12 and PP14 in the human endometriumJournal of Steroid Biochemistry, 1987
- Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (Gemeprost)Contraception, 1986
- Human decidua synthesizes placental protein 14 (PP 14) in vitroActa Endocrinologica, 1986
- Placental protein 14 (PP14) in late pregnancyArchiv für Gynäkologie, 1986
- Distribution of placental protein 14 in tissues and body fluids during pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- The relationship of placental protein 14 (PP14) in the mother and fetus to specific products of the human placentaPlacenta, 1985
- Termination of very early pregnancy by RU 486 — An antiprogestational compoundContraception, 1984
- Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range.BMJ, 1984
- The radioimmunoassay of human placental protein 14 (PP14)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancyClinica Chimica Acta; International Journal of Clinical Chemistry, 1979